Status:
UNKNOWN
Topical Silver Nanoparticles for Microbial Activity
Lead Sponsor:
Ahmed A. H. Abdellatif
Conditions:
Foot Infection Fungal
Infection, Bacterial
Eligibility:
All Genders
20-60 years
Phase:
PHASE1
Brief Summary
Silver nanoparticles are one of most nanoparticles use nowadays in the research area because it has specific physical and chemical properties, in medical fields silver nanoparticles can involve in dia...
Detailed Description
1. Preparation of vanishing cream Vanishing cream is an emulsion base which is oil in water, the oil phase gives the cream shine and pearl look because of stearic acid in the oil. To form an emulsion,...
Eligibility Criteria
Inclusion
- It is important to follow up and collect data, preferably for six months for the local and systemic activity of silver nanoparticles, to establish whether the infection recurrent or not.
Exclusion
- Larger numbers of participants having a different kind of skin infection are needed to test efficiency drug in order to produce more reliable data.
Key Trial Info
Start Date :
November 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 11 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03752424
Start Date
November 13 2019
End Date
January 11 2021
Last Update
October 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Buraidah Clinic
Buraidah, Al Qassim, Saudi Arabia, 51171